It has been demonstrated that blocking CD276 with monoclonal antibodies increases the tumor infiltration of CD8+ T cells and NK cells, reduces tumor growth, and prolongs survival in different mouse tumor models [40,41,42]. Here, CD8A is linked to neoplasm.